Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges
CNBC • U.S. • 1 hour ago
Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.
Related News
Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion …
CNBC
• 5 minutes ago
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion …
CNBC
• 31 minutes ago
McDonald's names company veteran Skye Anderson as its U.S. president as growth in its largest market slows
McDonald's new U.S. President Skye Anderson has been with the company for 26 years and succeeds Joe Erlinger in the rol…
CNBC
• 43 minutes ago
Trump and Republicans brand Democrats ‘communists’ amid progressive push
President Donald Trump and Republican allies are escalating attacks that label Democrats communists after progressive c…
CNBC
• 44 minutes ago
McDonald's earnings beat estimates, chain announces new U.S. head to accelerate growth
McDonald's stock has fallen more than 11% this year, dragging its market cap down to roughly $191 billion.
CNBC
• 35 minutes ago
McDonald’s revenue misses estimates as chain looks to accelerate U.S. growth
McDonald's stock has fallen more than 11% this year, dragging its market cap down to roughly $191 billion.
CNBC
• 44 minutes ago